Smoking and the risk of lung cancer: Susceptibility with GSTP1 polymorphisms

Epidemiology

Volumn 14, Issue 5, 2003, Pages 545-551

  Miller, David P ^a   Neuberg, Donna ^b   De Vivo, Immaculata ^a   Wain, John C ^c   Lynch, Thomas J ^c   Su, Li ^a   Christiani, David C ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Case control; GSTP1; Lung cancer; Susceptibility

Indexed keywords

CARCINOGEN; CIGARETTE SMOKE; DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; UNCLASSIFIED DRUG; GSTP1 PROTEIN, HUMAN; ISOENZYME;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; DETOXIFICATION; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; GSTP1 GENE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; UNITED STATES; GENETIC POLYMORPHISM; GENETICS; LUNG TUMOR; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 0642304620     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000073120.46981.24     Document Type: Article

References (26)

1. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;91:1194-1210. (in process citation)
2. th ed. New York: McGraw-Hill Health Professions Division; 1996.
3. Fields WR, Morrow CS, Doss AJ, et al. Overexpression of stably transfected human glutathione S-transferase P1-1 protects against DNA damage by benzo[a]pyrene diol-epoxide in human T47D cells. Mol Pharmacol. 1998;54:298-304.
4. Nakajima T, Elovaara E, Anttila S, et al. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis. 1995;16:707-711.
5. Ali-Osman F, Akande O, Antoun G, et al. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272:10004-10012.
6. Watson MA, Stewart RK, Smith GB, et al. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 1998;19:275-280.
7. Ryberg D, Skaug V, Hewer A, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 1997;18:1285-1289.
8. Butkiewicz D, Grzybowska E, Phillips DH, et al. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ Mo1 Mutagen. 2000;35:99-105.
9. Samet JM. The epidemiology of lung cancer. Chest. 1993;103(Suppl 1):20S-29S.
10. Samet JM, Wiggins CL, Humble CG, et al. Cigarette smoking and lung cancer in New Mexico. Am Rev Respir Dis. 1988;137:1110-3.
11. Randerath E, Randerath K. Monitoring tobacco smoke-induced DNA damage by 32P-postlabelling. IARC Sci Publ. 1993;124:305-314.
12. Jourenkova-Mironova N, Wikman H, Bouchardy C, et al. Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics. 1998;8:495-502.
13. London SJ, Daly AK, Cooper J, et al. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst. 1995;87:1246-1253.
14. To-Figueras J, Gene M, Gomez-Catalan J, et al. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1996;5:337-342.
15. Kihara M, Noda K. Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett. 1999;137:53-60.
16. Taioli E, Ford J, Trachman J, et al. Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis. 1998;19:813-817.
17. Garcia-Closas M, Kelsey KT, Wiencke JK, et al. A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States). Cancer Causes Control. 1997;8:544-553.
18. Nyberg F, Hou SM, Hemminki K, et al. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Cancer Epidemiol Biomarkers Prev. 1998;7:875-883.
19. Harris MJ, Coggan M, Langton L, et al. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics. 1998;8:27-31.
20. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis. 1978;118(6 Pt 2):1-120.
21. Cheng TJ, Christiani DC, Xu X, et al. Glutathione S-transferase mu genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol Biomarkers Prev. 1995;4:535-42.
22. st ed. New York: Wiley; 1989.
23. Hou SM, Ryberg D, Falt S, et al. GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients. Carcinogenesis. 2000; 21:49-54.
24. Rom WN, Hay JG, Lee TC, et al. Molecular and genetic aspects of lung cancer. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1355-1367.
25. To-Figueras J, Gene M, Gomez-Catalan J, et al. Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Control. 1999;10:65-70.
26. nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998.